(Q36695290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Prolactin acts as a potent survival factor for human breast cancer cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

A J Keith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

K L Goodhew

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

P B Savage

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Z E Winters

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J M P Holly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

305-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601947

30 December 2019

exact match

0 references

cites work

Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

The survival effect of prolactin on PC3 prostate cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

The role of prolactin in mammary carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Killing tumours by ceramide-induced apoptosis: a critique of available drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Mammary gland development and the prolactin receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

The prolactin/growth hormone receptor family: structure/function relationships

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Structural variants of prolactin: occurrence and physiological significance.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Hormonal changes following hypophysectomy in humans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Prolactin Suppresses Glucocorticoid-Induced Thymocyte Apoptosis in Vivo

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Glycosylated rat prolactin: isolation and structural characterization

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409804

Heterogeneity of circulating prolactin in the bitch

5 September 2018

1 reference

12 December 2020

Protective effect of prolactin and placental lactogen on NO-induced Nb2 lymphoma cell apoptosis

1 reference

12 December 2020

The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women

1 reference

12 December 2020

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial

1 reference

12 December 2020

[Diagnosis of breast carcinoma: comparative study of gray scale sonography and mammography]

1 reference

12 December 2020

Prolactin and breast cancer risk

1 reference

12 December 2020

Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide

1 reference

12 December 2020

Prolactin synthesis and secretion by human breast cancer cells

1 reference

12 December 2020

Expression of prolactin and its receptor in human breast carcinoma

1 reference

12 December 2020

Cellular expression of growth hormone and prolactin receptors in human breast disorders

1 reference

12 December 2020

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Prolactin as a Chemoattractant for Human Breast Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601947

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15213724%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference